Therapeutic Asset Ratings

278 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Ganetespib Angiosarcoma	QuantumLeap Healthcare Collaborative	P2	CCC (51)
Ganetespib Hormone Receptor Negative Tumor	QuantumLeap Healthcare Collaborative	P2	CCC (51)
Ganetespib Hormone Receptor Positive Tumor	QuantumLeap Healthcare Collaborative	P2	CCC (51)
Gsk 5733584 Triple-Negative Breast Carcinoma	QuantumLeap Healthcare Collaborative	P2	CCC (51)
Lasofoxifene Triple-Negative Breast Carcinoma	QuantumLeap Healthcare Collaborative	P2	CCC (51)
mk-2206 Angiosarcoma	QuantumLeap Healthcare Collaborative	P2	CCC (51)
mk-2206 Hormone Receptor Negative Tumor	QuantumLeap Healthcare Collaborative	P2	CCC (51)
mk-2206 Hormone Receptor Positive Tumor	QuantumLeap Healthcare Collaborative	P2	CCC (51)
N-DESMETHYL-4-HYDROXYTAMOXIFEN Triple-Negative Breast Carcinoma	QuantumLeap Healthcare Collaborative	P2	CCC (51)
Pexidartinib Triple-Negative Breast Carcinoma	QuantumLeap Healthcare Collaborative	P2	CCC (51)
Trebananib Triple-Negative Breast Carcinoma	QuantumLeap Healthcare Collaborative	P2	CCC (51)
Vepdegestrant Triple-Negative Breast Carcinoma	QuantumLeap Healthcare Collaborative	P2	CCC (51)
vv1 Triple-Negative Breast Carcinoma	QuantumLeap Healthcare Collaborative	P2	CCC (51)
IMMUNOGLOBULIN G, ANTI-(HUMAN INSULIN-LIKE GROWTH FACTOR I RECEPTOR) (HUMAN MONOCLONAL HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL LIGHT CHAIN, DIMER Breast Tumors	QuantumLeap Healthcare Collaborative	P2	CCC (50)
Nelitolimod Angiosarcoma	QuantumLeap Healthcare Collaborative	P2	CCC (50)
Nelitolimod Hormone Receptor Negative Tumor	QuantumLeap Healthcare Collaborative	P2	CCC (50)
Nelitolimod Hormone Receptor Positive Tumor	QuantumLeap Healthcare Collaborative	P2	CCC (50)
Nelitolimod Triple-Negative Breast Carcinoma	QuantumLeap Healthcare Collaborative	P2	CCC (49)
arx788 Her2-Receptor Negative Breast Cancer	QuantumLeap Healthcare Collaborative	P2	CCC (48)
ARX 788 HER2-negative Breast Cancer	QuantumLeap Healthcare Collaborative	P2	CCC (48)
ARX 788 HER2-positive Breast Cancer	QuantumLeap Healthcare Collaborative	P2	CCC (48)
Dan-222 Breast Neoplasm	QuantumLeap Healthcare Collaborative	P2	CCC (48)
Dan-222 HER2 Positive Breast Carcinoma	QuantumLeap Healthcare Collaborative	P2	CCC (48)
Datopotamab Deruxtecan Breast Neoplasm	QuantumLeap Healthcare Collaborative	P2	CCC (48)
Datopotamab Deruxtecan HER2 Positive Breast Carcinoma	QuantumLeap Healthcare Collaborative	P2	CCC (48)

Showing 126 to 150 of 278 assets

PreviousPage 6 of 12Next